On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Tao Yang

ResearcherPublications, citations & collaboration network

Tao Yang is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Tao Yang have?

ScholarIQindexed works

Tao Yang has 75 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Tao Yang have?

ScholarIQcitation count

Tao Yang has 1,027 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Tao Yang?

ScholarIQh-index

Tao Yang has an h-index of 20 in OpenAlex.

What is the i10-index of Tao Yang?

ScholarIQi10-index

Tao Yang has an i10-index of 33 in OpenAlex.

What is the ORCID of Tao Yang?

ScholarIQorcid

The ORCID for Tao Yang is on the source record.

What is the OpenAlex record for Tao Yang?

ScholarIQopenalex

The OpenAlex for Tao Yang is on the source record.

What are the most-cited papers on Tao Yang?

ScholarIQmost cited works
Eye-Wearable Technology for Machine Maintenance
Xianjun Sam Zheng, Cédric Foucault, Patrik Matos da Silva, Siddharth Dasari, Tao Yang, Stuart Goose
201590 Citations
lncRNA PVT1 and its splicing variant function as competing endogenous RNA to regulate clear cell renal cell carcinoma progression
Tao Yang, Hui Zhou, Peijun Liu, Libin Yan, Weimin Yao, Ke Chen, Jin Zeng, Heng Li, Junhui Hu, Hua Xu, Zhangqun Ye
Oncotarget. 201768 CitationsOPEN ACCESS
Huachansu suppresses human bladder cancer cell growth through the Fas/Fasl and TNF- alpha/TNFR1 pathway in vitro and in vivo
Tao Yang, Runlin Shi, Lei Chang, Kun Tang, Ke Chen, Yu Gan, Yuanfeng Tian, Yonglian Guo, Wei He, Xiaodong Song, Hua Xu, Zhangqun Ye
Journal of Experimental & Clinical Cancer Research. 201566 CitationsOPEN ACCESS
miR-122 Inhibits Hepatocarcinoma Cell Progression by Targeting LMNB2
Xiaona Li, Hong Yang, Tao Yang
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 201945 CitationsOPEN ACCESS
<i>TACC3</i> overexpression in cholangiocarcinoma correlates with poor prognosis and is a potential anti-cancer molecular drug target for HDAC inhibitors
Junchuang He, Wei Yao, Jianming Wang, Peter Schemmer, Yan Yang, Yan Liu, Yawei Qian, Weipeng Qi, Jian Zhang, Qi Shen, Tao Yang
Oncotarget. 201644 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account